Key2brain Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Key2brain General Information

Description

Operator of a biotechnology company intended to develop novel and efficacious brain-targeting platform technology. The company provides tech systems for enhanced brain uptake of biologics and diagnostics for treating the central nervous system (CNS), enabling clients to improve treatment and diagnostic options for diseases of the central nervous system (CNS).

Contact Information

Website
www.key2brain.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Karolinska Institute Campus, Innomedicum
  • A Working Lab (AWL) Nanna Svartz Väg 4
  • 171 65 Solna
  • Sweden
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • Karolinska Institute Campus, Innomedicum
  • A Working Lab (AWL) Nanna Svartz Väg 4
  • 171 65 Solna
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Key2brain Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Dec-2023 Completed Clinical Trials - General
3. Early Stage VC 01-May-2023 Completed Clinical Trials - General
2. Seed Round 01-Jan-2022 $78.3K $78.3K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Key2brain’s complete valuation and funding history, request access »

Key2brain Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view Key2brain’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Key2brain Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Key2brain Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023385035-A1 Vhh antibodies and uses thereof Pending 23-Nov-2022
AU-2023385036-A1 Vhh antibodies and uses thereof Pending 23-Nov-2022
EP-4622667-A1 Vhh antibodies and uses thereof Pending 23-Nov-2022
EP-4622668-A1 Vhh antibodies and uses thereof Pending 23-Nov-2022
US-20260116990-A1 Vhh antibodies and uses thereof Pending 23-Nov-2022 C07K16/2881
To view Key2brain’s complete patent history, request access »

Key2brain Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Key2brain Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
DRIVE (KI Innovations Business Incubator) Accelerator/Incubator
Life Science Invest Angel Group Minority
Phase2Phase Biopharma Venture Capital Minority
Uppsala Innovation Centre Accelerator/Incubator
To view Key2brain’s complete investors history, request access »

Ready to get started?

Request a free trial

Key2brain FAQs

  • When was Key2brain founded?

    Key2brain was founded in 2020.

  • Where is Key2brain headquartered?

    Key2brain is headquartered in Solna, Sweden.

  • What is the size of Key2brain?

    Key2brain has 10 total employees.

  • What industry is Key2brain in?

    Key2brain’s primary industry is Drug Discovery.

  • Is Key2brain a private or public company?

    Key2brain is a Private company.

  • What is Key2brain’s current revenue?

    The current revenue for Key2brain is .

  • How much funding has Key2brain raised over time?

    Key2brain has raised $78.3K.

  • Who are Key2brain’s investors?

    DRIVE (KI Innovations Business Incubator), Life Science Invest, Phase2Phase Biopharma, and Uppsala Innovation Centre have invested in Key2brain.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process